- 2021-10-28
chinese pharmaceutical companies are turning their attention to innovation, shifting rapidly from mastery of follow-on drugs to researching first-in-class and best-in-class drugs. aiming to be a healthcare group with a global presence, fosun pharma, established in shanghai in 1994, has built its core business around innovative drug r&d and manufacturing.
- 2021-10-07
on november 6, 2021, as a parallel supporting event of the 4th china international import expo (ciie), the 4th hongqiao international health technology innovation forum with the theme of "innovation for good health" was successfully held. this forum was sponsored by the international health exchange and cooperation center nhc prc (ihecc) and china pharmaceutical innovation and research development association,
- 2021-09-28
in this meeting, henlius releases phase 2 study results of serplulimab (hlx10, novel anti-pd-1 antibody), in patients with advanced cervical cancer in an oral presentation.
- 2021-09-28
in this meeting, henlius releases phase 3 study results of hlx04 (bevacizumab biosimilar), in patients with metastatic colorectal cancer in an oral presentation.
